- Fund Type: Open-End Fund
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
CI Global Health Sciences Corporate Class
+ Add to WatchlistUNISHSCI:CN
36.51 CAD 0.51 1.42%As of 07:59:30 ET on 05/17/2013.
Snapshot for CI Global Health Sciences Corporate Class (UNISHSCI)
| Year To Date: | +29.38% | 3-Month: | +16.42% | 3-Year: | +23.27% | 52-Week Range: | 23.61 - 36.51 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +6.79% | 1-Year: | +54.39% | 5-Year: | +13.26% | Beta vs CXBT: | 0.68 |
Fund Profile & Information for UNISHSCI
CI Global Health Sciences Corporate Class is an open-end fund incorporated in Canada. The Fund seeks to obtain maximum long-term capital growth. The Fund invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry.
| Inception Date: | 07-23-1996 | Telephone: | 1-800-268-9374 |
|---|---|---|---|
| Managers: | ANDREW WAIGHT | ||
| Web Site: | www.cifunds.com | ||
Fundamentals for UNISHSCI
| NAV | (on 2013-05-17) 36.51 |
|---|---|
| Assets (M) | (on 2013-03-28) 112.46 |
| Fund Leveraged | N |
| Minimum Investment | 500.00 |
| Minimum Subsequent Investment | 50.00 |
Dividends for UNISHSCI
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Annual |
| Last Dividend Net | (on 2012-12-14) 0.28 |
| Dividend Yield (ttm) | 0.78 |
Fees & Expenses for UNISHSCI
| Front Load | 5.00 |
|---|---|
| Back Load | 5.50 |
| Current Mgmt Fee | 2.00 |
| Redemption Fee | 2.00 |
| 12b1 Fee | - |
| Expense Ratio | 2.22 |
Top Fund Holdings for UNISHSCI
Filing Date: 01/31/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| HealthSouth Corp | 335,000 | 7,971,497 | 5.694% |
| Boston Scientific Corp | 1,029,700 | 7,671,070 | 5.479% |
| Roche Holding AG | 33,400 | 7,370,419 | 5.264% |
| BioMarin Pharmaceutical Inc | 119,900 | 6,563,524 | 4.688% |
| Novartis AG | 80,000 | 5,434,604 | 3.882% |
| GlaxoSmithKline PLC | 232,201 | 5,308,931 | 3.792% |
| Patheon Inc | 1,437,139 | 5,288,672 | 3.777% |
| Brookdale Senior Living Inc | 180,000 | 4,848,660 | 3.463% |
| Sanofi | 49,000 | 4,768,091 | 3.406% |
| Merck & Co Inc | 110,000 | 4,744,642 | 3.389% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page